Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 58% ± 10% | |
lung | 17 studies | 53% ± 15% | |
intestine | 13 studies | 48% ± 23% | |
eye | 11 studies | 41% ± 22% | |
kidney | 9 studies | 47% ± 21% | |
brain | 9 studies | 30% ± 11% | |
lymph node | 7 studies | 56% ± 22% | |
liver | 7 studies | 45% ± 23% | |
bone marrow | 5 studies | 41% ± 16% | |
uterus | 5 studies | 57% ± 13% | |
pancreas | 4 studies | 76% ± 9% | |
prostate | 4 studies | 31% ± 11% | |
breast | 4 studies | 49% ± 7% | |
placenta | 3 studies | 59% ± 22% | |
ovary | 3 studies | 49% ± 9% | |
skin | 3 studies | 33% ± 9% | |
thymus | 3 studies | 70% ± 34% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7442.00 | 1445 / 1445 | 100% | 142.14 | 183 / 183 |
lung | 100% | 9087.18 | 578 / 578 | 100% | 189.34 | 1155 / 1155 |
ovary | 100% | 12402.69 | 180 / 180 | 100% | 229.11 | 430 / 430 |
stomach | 100% | 5669.07 | 359 / 359 | 100% | 154.83 | 286 / 286 |
thymus | 100% | 10833.66 | 653 / 653 | 100% | 324.44 | 604 / 605 |
prostate | 100% | 9236.96 | 245 / 245 | 100% | 219.53 | 501 / 502 |
uterus | 100% | 10498.84 | 170 / 170 | 100% | 376.10 | 458 / 459 |
intestine | 100% | 8559.94 | 966 / 966 | 99% | 175.61 | 524 / 527 |
skin | 100% | 9510.19 | 1809 / 1809 | 99% | 195.88 | 469 / 472 |
brain | 99% | 4880.11 | 2628 / 2642 | 100% | 193.43 | 704 / 705 |
breast | 100% | 8423.90 | 459 / 459 | 99% | 239.81 | 1110 / 1118 |
bladder | 100% | 7634.71 | 21 / 21 | 99% | 231.61 | 500 / 504 |
pancreas | 100% | 4635.08 | 327 / 328 | 99% | 147.00 | 176 / 178 |
adrenal gland | 100% | 7120.67 | 258 / 258 | 94% | 126.35 | 216 / 230 |
kidney | 100% | 6600.06 | 89 / 89 | 94% | 120.83 | 843 / 901 |
liver | 99% | 3174.38 | 223 / 226 | 93% | 101.70 | 378 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 314.04 | 29 / 29 |
spleen | 100% | 10198.67 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 371.90 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 72.25 | 1 / 1 |
blood vessel | 100% | 8446.37 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 7355.99 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 10894.48 | 925 / 929 | 0% | 0 | 0 / 0 |
muscle | 98% | 4580.40 | 788 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 3715.13 | 818 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 78.48 | 73 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0005615 | Cellular component | extracellular space |
GO_0000785 | Cellular component | chromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0031492 | Molecular function | nucleosomal DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | HMGN2 |
Protein name | Non-histone chromosomal protein HMG-17 (High mobility group nucleosome-binding domain-containing protein 2) |
Synonyms | HMG17 |
Description | FUNCTION: Binds to the inner side of the nucleosomal DNA thus altering the interaction between the DNA and the histone octamer. May be involved in the process which maintains transcribable genes in a unique chromatin conformation (By similarity). . |
Accessions | ENST00000361427.6 P05204 |